-
Workshop: artificial intelligence in medicines regulation
Workshop: artificial intelligence in medicines regulation
-
Workshop: artificial intelligence in medicines regulation
Workshop: artificial intelligence in medicines regulation
Follow live broadcast of virtual workshop on 20 April (14:45 to 18:00 CEST) on state-of-the art use of artificial intelligence in medicines regulation
-
Update on investigation of COVID-19 Vaccine Janssen
Update on investigation of COVID-19 Vaccine Janssen
-
Update on investigation of COVID-19 Vaccine Janssen
Update on investigation of COVID-19 Vaccine Janssen
Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing very rare cases of unusual blood clots that occurred in the United States following the use of Janssen’s
-
EMA continues to monitor COVID-19 vaccine AstraZeneca
EMA continues to monitor COVID-19 vaccine AstraZeneca
-
EMA continues to monitor COVID-19 vaccine AstraZeneca
EMA continues to monitor COVID-19 vaccine AstraZeneca
EMA to provide further context on risk of very rare blood clots with low blood platelets that occurred after vaccination with Vaxzevria
-
PRAC highlights April 2021
PRAC highlights April 2021
-
PRAC highlights April 2021
PRAC highlights April 2021
Outcomes from the April meeting cover all aspects of the risk management of the use of medicines, including COVID-19 vaccines
